Instructions for Authors
Updated April 1999

  • Manuscript Information
  • Authorship
    • Financial Disclosure
    • Copyright Transfer
    • Editorial Review and Processing
       
  • Manuscript Preparation
    • Informed Consent
    • Financial/Proprietary Interest
    • Abstracts
    • References

MANUSCRIPT CRITERIA AND INFORMATION

Note: Please read these instructions carefully technical deficiencies must be corrected before manuscripts can be reviewed.

Send manuscript to the Editor: Ercan Öngör,  Editor
Millet Cad. Gülşen Apt. No:21 D:9 K:4 Yusufpaşa Aksaray İSTANBUL
 

Manuscripts are received with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium. A complete manuscript submitted following oral presentation that results in the publication of including substantive information elsewhere, magazines, or "tabloids," may be deemed ineligible for publication in the TJO. The TJO is willing to receive and evaluate manuscripts submitted following presentation or publication of preliminary findings (eg, in an abstract) at a major meeting, but only if publication in other print media is not under consideration. Press reports of the meeting should not be amplified by additional data or copies of tables and illustrations. When submitting a paper, authors should include copies of possibly duplicative material that has been previously published or is currently being considered elsewhere. If after submission but before publication of a manuscript, publication of the findings occurs in press reports, interviews, or other formats, the Editors should be notified.



Authorship

Title Page. Give full names, highest academic degrees, and affiliations of all authors. Designate a corresponding author and include a complete mailing address, telephone number, fax number, and e-mail address. Specify the address to which requests for reprints should be sent. Manuscripts should have no more than 6 authors; a greater number requires justification.

Group Authorship. If authorship is attributed to a group (either solely or in addition to 1 or more individual authors), all members of the group must meet the full criteria and requirements for authorship described in the following paragraphs. One or more authors may take responsibility for a group, eg, Jane Doe for the Collaborative Study Group, in which case the other group members are not authors, but may be listed in an acknowledgment. To save space, if group members have been listed in the TJO, the article will be referenced rather than reprinting the list.

Authorship Requirements. The following 3 statements must be signed by all listed authors and submitted in a cover letter (or by using the form following these "Instructions") prior to our sending a manuscript out for review: (1) statement on authorship responsibility, (2) statement on financial disclosure.

Authorship Responsibility. I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (when applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the submitted manuscript and approve it for publication. Neither this manuscript nor one with substantially similar content under my authorship has been published or is being considered for publication elsewhere, except as described in an attachment. If requested, I shall produce the data upon which the manuscript is based for examination by the editors or their assignees."

Financial Disclosure. I certify that any affiliations with or involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the manuscript (eg, employment, consultancies, stock ownership, honoraria, expert testimony) are disclosed below."

Research or project support should be listed in an acknowledgment.

Copyright Transfer. The author(s) undersigned hereby transfers, assigns, or otherwise conveys all copyright ownership to the TJO in the event that such work is published by the TJO."



Editorial Review and Processing

Peer Review. Manuscripts are sent to expert consultants for peer review. Peer reviewer identities are kept confidential. Authors, by special request, may keep their identities confidential but must submit 1 original and 3 copies of the manuscript with all identifying information edited out.

Accepted Manuscripts. Accepted manuscripts become the permanent property of the TJO and may not be published elsewhere without permission from the publisher (TJO). Selected manuscripts may also appear on the TJO Web site at http://www.tjo.com

Editing. Accepted manuscripts are edited according to TJO style and returned to the author for approval. Authors are responsible for all statements made in their work, including changes made by the copy editor and authorized by the corresponding author. If you wish to receive page proofs for approval, contact the copy editor assigned to your paper within 2 days of receiving the typescript.

Reprints. Reprint order forms are included with the edited typescript sent for approval to authors. Reprints are shipped 6 to 8 weeks after publication.

Return of Manuscripts. Owing to postage costs, rejected and revised manuscripts will not be returned to authors. Original illustrations, photographs, and slides will be returned. To ensure confidentiality, the manuscript and all copies will be destroyed.



Manuscript Preparation

Text. The TJO requirements are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (JAMA. 1993;269:2282-2286). Submit an original typescript and 2 high-quality copies. All copy (including references, legends, and tables) must be typed double-spaced on 21.6 × 27.9-cm (8-1/2 × 11-in) paper. Margins of at least 2.5 cm (1 in) must be provided. If a word processor is used, do not justify the right margin. The text should, in general, not exceed 12 double-spaced typewritten pages. Each manuscript component should be in the following sequence: title page, abstract, text, acknowledgments, references, tables (each table complete with title and footnotes on a separate page), and figure legends. Pages should be sequentially numbered in the lower-center, beginning with the title page.

Titles. Titles should be short, specific, and clear and typed on a special page. They should not exceed 42 characters per line, including punctuation and spaces, and be limited to 2 lines, if possible. The title page should include the first name, middle initial, and last name of all authors with their highest academic degree and the professional affiliation of all authors with city location. It should also include the address to which requests for reprints should be sent.

Informed Consent. Manuscripts describing experimental investigation of human subjects should state formally in the "Methods" section that an appropriate institutional review board has approved the project and/or informed consent has been obtained from all adult participating subjects and from parents or legal guardians of participating minors. Refer to patients by number, eg, patient 1 (or, in anecdotal reports, by fictitious given names).

Financial/Proprietary Interest. If the article discusses in any way a device, equipment, an instrument, or a drug, the authors must state in a footnote whether they do or do not have any commercial or proprietary interest in the product or company. Likewise, they must reveal whether they have any financial interest or receive payment as a consultant, reviewer, or evaluator.

Abstracts. The structured abstract will be used for manuscripts in the following categories: Clinical Sciences, Epidemiology and Biostatistics, Laboratory Sciences, Socioeconomics, and Ophthalmic Molecular Genetics. The abstract should not exceed 200 words and should include the following headings: Pupose(s), Methods or Design, Results, and Conclusions. The Methods or Design section should contain a description of setting, intervention, and main outcome measures, where applicable. Abstracts for Laboratory Science and Ophthalmic Molecular Genetics sections should also include a Clinical Relevance heading. Free-form abstracts of 135 words or less will be used for Mechanisms of Ophthalmic Disease, Clinicopathologic Reports, New Instruments, Surgical Techniques, Special Articles, and Ophthalmology in Other Countries. No abstracts are required for Correspondence, Case Reports, Small Case Series, Editorials, or Photo Essays.

The main point of the article should be included in the first paragraph of the discussion.

References. List references in numerical order (not alphabetically). Once a reference is cited, all subsequent citations should be to the original number. All references must be cited in the text or tables. Unpublished data and personal communications should not be listed as references but parenthetically within the text. References to journal articles should include (1) author(s) (if more than , write "et al" after the third name), (2) title, (3) journal name (as abbreviated in Index Medicus), (4) year, (5) volume number, and (6) inclusive page numbers, in that order. References to books should include (1) author(s), (2) chapter title (if any), (3) editors (if any), (4) title of book, (5) city of publication, (6) publisher, (7) year, and (8) page(s), if indicated. Authors are responsible for the accuracy of references.

SI Units. Use Système International (SI) measurements throughout the manuscript. (Exceptions are visual acuity measurements and intraocular pressure recordings.)

Illustrations. Use only those illustrations that clarify and augment the text. More than 10 total illustrations per manuscript would have to be justified. Submit 4 copies of illustrations (preferably 5 × 7 in), unmounted and untrimmed, with each set separately packaged. Do not send original artwork. Send high-contrast glossy prints or original laser prints. Figure number, name of senior author, and arrow indicating "top" should be typed on a gummed label and affixed to the back of each illustration. Illustrations submitted for publication may be relettered to achieve uniformity of lettering style throughout the journal. Magnification and stain should be provided when pertinent. If a specific figure arrangement is desired, please include a photocopied layout. Because of space limitations, the editors ask that authors crop out all extraneous portions on clinical photographs, CT scans, and ultrasound images (for example, identifying features or patient names), or indicate crop marks on photo margins. Digital Enhancement of Images. Digitally enhanced images (CT/MRI, blots, photographs, photomicrographs, ultrasound images, x-ray films, etc) must be clearly identified in the figure legends as digitally processed images. Please include and clearly label 3 copies of the processed and original images for review by our referees. Legends. Legends must be typed double-spaced, beginning on a separate sheet of paper. Length should be limited to a maximum of 40 words and should allow the illustration to be fully understandable without recourse to the text. Use arrows, letters, etc, for enhanced understanding.

Return to back

 

Home | News | Current Issue | Past Issues | Calendar of events
Subscriptions | Links | Authors | About | Search

E-mail us your comments and suggestions at info@tod-tog.com
©2001 Journal of Turkish Ophthalmology All Rights Reserved.